Semax

Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment ACTH(4-10) with an added C-terminal Pro-Gly-Pro sequence. Originally developed for neuroprotection research, this peptide has been extensively studied in neuroscience and cognitive function investigations. Research focuses on Semax's effects on brain-derived neurotrophic factor (BDNF) expression, neuroplasticity, neurotransmitter systems, cerebral circulation, and cognitive performance. Scientists investigate its mechanisms of neuroprotection, including antioxidant properties, modulation of dopamine and serotonin systems, and enhancement of neuronal survival under stress conditions. Studies examine its potential in attention, memory formation, learning processes, and recovery from neurological challenges. The peptide is valuable for understanding neurotrophic factor regulation, synaptic plasticity, and the molecular basis of cognitive enhancement. Researchers utilize Semax to explore novel approaches in neuroscience and mechanisms of brain function optimization.